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ABSTRACT 
 
In this paper, we propose a new method for automated delineation of tumor boundaries in whole-body PET/CT by 
jointly using information from both PET and diagnostic CT images.  Our method takes advantage of initial robust hot 
spot detection and segmentation performed in PET to provide a conservative tumor structure delineation. Using this 
estimate as initialization, a model for tumor appearance and shape in corresponding CT structures is learned and the 
model provides the basis for classifying each voxel to either lesion or background class.  This CT classification is then 
probabilistically integrated with PET classification using the joint likelihood ratio test technique to derive the final 
delineation. More accurate and reproducible tumor delineation is achieved as a result of such multi-modal tumor 
delineation, without additional user intervention.   The method is particular useful to improve the PET delineation result 
when there are clear contrast edges in CT between tumor and healthy tissue, and to enable CT segmentation guided by 
PET when such contrast difference is absent in CT.   
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1.  INTRODUCTION 
 
Fluorodeoxyglucose (FDG)-positron emission tomography (PET) is a whole-body imaging technique that has been 
recognized as an effective tool for diagnosis, prognosis, staging and response to therapy in oncological imaging.  During 
a FDG-PET scan, a tracer dose of the radioactive material, FDG, is injected intravenously.  The FDG uptake is 
increased in cells with high metabolic rate, hence diseased areas (such as tumor, inflammation) in FDG-PET appear as 
high-uptake hot spots.  
 
The problem of accurate delineation of tumor boundaries with high reproducibility is essential for radiation therapy in 
critical regions such as head or volumetric assessment of tumor growth and therapy response. There has been prior work 
on tumor detection, segmentation, quantitative measurement of tumor volume and change quantification in PET from 
both clinical study literature
 5, 6, 7, 8 and medical image processing literature 
10, 11.  Most approaches use the standard 
uptake value (SUV), which is a semi-quantitative normalization of the FDG uptake in PET images and measures the 
FDG concentration normalized by decay corrected injection dose per gram body mass. Physicians and radiologists have 
used this measure for normalization across time points and across different patients, and the maximum SUV values are 
used for grading tumors. Typically hot spots are detected as local regions with high SUV values, and segmentation 
algorithms apply thresholds that relate to the maximum SUV value.  However, precise delineation of the hot spot 
boundary from PET alone remains challenging, because intensity decreases smoothly and gradually from the hot spot 
core to normal tissue and there is no sharp contrast separating diseased and healthy tissue.  There are also the issues with 
intrinsic imaging pitfalls and artifacts in PET 
10, 14 and the lack of ground truth for validating proposed algorithms. 
 
The PET/CT technology combines functional PET and anatomical CT scanning technologies and allows the acquisition 
of clinical quality PET and CT scans, accurately aligned, from a single imaging device 
13.  On the fused PET/CT image, 
abnormalities that are seen on PET can be located, and possibly also confirmed, on CT, and this enables the interpreting 
physician to make a more informed decision about whether the hot spot on PET is indeed an abnormality, and if so, 
where the abnormality is located anatomically. Retrospective studies performed with PET/CT prototypes showed 
considerable promise, particularly in the areas of disease staging and therapy planning and monitoring.  
Previous works on PET/CT image analysis, change quantification, and visualization 
15, 16 have mostly focused on 
registration and fusion to compensate for movements/deformations due to patient positioning, physiological organ 
motion, or structural changes as a result of disease progression or remission.  These registration methods have 
demonstrated success in correcting organ (such as breast, lung, liver) motion.  There is little work on utilizing PET/CT 
information to improve segmentation (e.g. tumor boundary delineation) accuracy.  CT provides higher spatial resolution 
compared to PET, however automated segmentation algorithms often fail when used on CT data alone because the 
attenuation difference between tumor and surrounding health tissue is often too low to show clear contrast edges in CT. 
On the other hand, the gradual change of intensity in PET images makes it difficult to delineate tumor boundary 
precisely using PET alone. 
 
In this paper, we propose a new method for automated delineation of tumor boundaries in whole-body PET/CT by 
jointly using information from both PET and diagnostic CT images. The method exploits complementary information 
from PET and CT, improving the PET delineation result when there are clear contrast edges in CT, and enabling CT 
segmentation guided by PET when contrast difference is absent in CT.  Combining the high-sensitivity for detection of 
cancerous tissue in PET and superior spatial resolution of complementary diagnostic CT images, we show that efficient, 
robust and reproducible segmentation can be achieved with minimal user interaction, assuming ideal registration of 
PET/CT. 
 
2.  METHOD 
 
Our method has two major components based on our recent research: (1) the one-click tumor delineation algorithm for 
whole-body PET based on mode-seeking region growing 
1 for robust and reproducible tumor delineation in PET, and (2) 
CT segmentation based on intensity likelihood ratio test 
2.  The method takes advantage of an initial robust segmentation 
performed in PET, to learn a model for tumor appearance and shape in corresponding CT structures. More accurate and 
reproducible tumor delineation can be achieved as a result of such multi-modal tumor delineation, without additional 
user intervention.  The algorithm consists of the following main steps. 
2.1. Lesion detection and robust lesion segmentation in PET 
 
A region with high FDG uptake is initially detected in PET by the physician or using an automated hot-spot detection 
algorithm 
1.  
 
This region may potentially include several local hot spots.  In order to obtain a reliable initial segmentation of hot 
spots, we apply a Mode-Seeking Region Growing segmentation algorithm (MSRG) .  Mode-seeking is the process of 
finding voxel locations with local maximum SUV values (SUVmax) within the region of interest.  In this step, we start 
from each seed point as a probe on the 4-D surface as defined by the spatial coordinates (x,y,z) and the corresponding 
SUV intensity ISUV(x,y,z). At the probe point, we find the maximum SUV value within its local neighbourhood and then 
move the probe to the point with that maximum. The process continues until the probe reaches the intensity mode in the 
given region of interest.  By starting the mode-seeking procedure from many seed points uniformly distributed within a 
VOI, we can detect all the SUV-maxima points that correspond to the primary locations of true hot spots. SUV images 
tend to be locally smooth, which facilitates the mode-seeking processes even with a relatively low number of seed 
points.   
 
Next we apply 3D region growing, originated from the detected local modes, with a fixed threshold of 40% of the 
corresponding SUVmax value. This produces a conservative segmented lesion mask in PET, based on a clinically 
meaningful threshold that has been utilized in the literature
7.  Radiologists commonly use the maximum SUV value of a 
tumour candidate in order to grade the disease and help determine its spatial extent 
6, 8, 9. Hence, the segmentation based 
on maximum local SUV value produces results consistent with the clinically used criteria.  Overall the mode-seeking 
region growing method has been validated extensively and it produces accurate, reproducible results that are not 
sensitive to the seed point. 
 2.2. Modeling tumor appearance in CT by weighted non-parametric density estimate  
 
Let us denote the segmented hot spot areas by mode-seeking region growing as VOIin.  We consider VOIin only 
containing lesion tissue because of the conservative 40% of SUVmax threshold.  We then obtain another volume of 
interest , VOIout, which is considered to contain only non-lesion tissue, by first dilating generously the original mask 
VOIin using a 3D structuring element and then excluding VOIin from the dilated mask.  Morphological operations are 
restricted to respect other pre-segmented structures, including body outline, heart and other detected hotspots. 
 
A probabilistic model of tissue attenuation in CT in both the segmented tumor (i.e. lesion) as well as in the background 
(i.e. non-lesion) can be obtained in terms of CT intensity likelihood functions using weighted non-parametric density 
estimates.  Let the CT value, ICT(x), at a voxel, x, be  α, then we can approximate the likelihood of this intensity, in a 
lesion, or outside a lesion by:  
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Where α refers to CT intensity value, Kσ is a 3-dimensional kernel function with bandwidth σ, VOIin and VOIout are spatial 
supports based on PET lesion segmentation, V is a volume normalization factor.  (( ) ) SUV g Iy i n ,  (( ))
SUV g Iy o u t  model the 
likelihood of tumor appearance at voxel y in PET, and they are defined by: 
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where β is a parameter defining the extent of CT density estimates weighting (determined empirically for a given 
clinical application and fixed, in our test cases β = 0.4), ISUV (y)  is the SUV intensity at voxel y normalized to [0,1] and 
,, τυψ  scale and center the sigmoid function so that 
max (40% ) 0.5 gS U V i n = . The function is adjusted accordingly if a 
different threshold was used to obtain PET segmentation. 
 
 
2.3. Joint Likelihood Ratio Test 
 
A joint-likelihood ratio r(x) is calculated on a voxel-by-voxel basis in the joint PET-CT domain to provide a measure of 
voxel being containing lesion tissue as opposed to being in background, assuming PET and CT are independent given 
the ground truth classification for in and out.   
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In the Eq. (5) above, the likelihood functions, L , are defined based on f and g likelihoods in Eqs. (1)~(4), and are 
evaluated on an isotropic grid using linear interpolation of CT and SUV intensity values. Tumor-background membership is determined by binary classification of each voxel to be within either VOIin  or VOIout using the likelihood 
ratio test
2, which is basically a thresholding operation on r(x) using the threshold 1.0.  The likelihood ratio test and class 
membership assignment are repeated for a fixed number of iterations to reach a stable value (in our case, n=3 was 
determined empirically as a suitable parameter).  
 
If PET is only used for hot-spot detection and producing the initial volume estimate for tumor foreground and 
background appearance modeling in CT, the previous equation simplifies as 
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Optionally, to prevent the segmentation result on CT from flooding away in case of adjacent structures having identical 
attenuation, a constraint on segmented tumor shape can be imposed in terms of a Gaussian spatial likelihood function as 
in 
4. The center, scale and anisotropy of the Gaussian are determined from VOIin.  
 
 
3.  DATA 
 
We have tested the algorithm on multiple patient studies with lung and liver tumors identifiable in both the PET scan 
and the corresponding diagnostic CT scan acquired using the same scanner.  In some datasets a difference in respiration 
protocol between PET, CT resulted in spatial mismatch between PET and CT tumor centre locations. These images 
were then semi-automatically registered.  
 
The lung cancer datasets included four patients with a total of six tumors of different shapes. The liver cancer datasets 
included one patient with three liver tumors and there are three independent studies acquired several months apart for 
this patient.  
 
 
 
4.  RESULTS 
 
The system has produced robust results on segmenting liver and lung tumors in multiple patients based on PET and 
diagnostic CT scans. The expert ground truth segmentation was not available for the studied cases and therefore we 
performed a qualitative assessment.  
 
4.1. Liver tumors   
 
Tumour boundaries are visible on CT but cannot be reliably segmented using CT data alone 
2 due to low intensity 
gradient in the tumour boundaries. In PET, the segmentation is affected by high natural FDG uptake in liver. Our joint 
PET/CT algorithm with conservative initial threshold gives good segmentation of tumors located in high-activity 
regions, which cannot be segmented automatically by using PET alone.  
 
 
Figure 1 shows example segmentation results for various lesions of hepatocellular carcinoma. The segmentation worked 
well for varying maximum SUVmax in the tumours  in images acquired at 3 time points at different stages of disease 
development. Joint PET-CT segmentation enabled more accurate apparent localization of tumour boundaries and 
volume and can provide valid segmentation even if the default PET segmentation threshold (40%) fails due to high 
activity in neighboring regions.  
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Figure 1  From left: liver lesion in CT image (1), PET-only result (2), new PET-CT algorithm result  (3), binary 
difference image defined as 3-2 (4). Top row: coronal plane, bottom: axial plane.  
 
Along the boundaries of liver tumors shown in Figure 1, the intensity gradients are very low compared to gradients 
separating other structures in the image, as can be seen from Figure 2. Therefore, many methods based on CT intensity 
alone will fail.   
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Figure 2  The intensity profiles of liver tumor (Figure 1 A) and lung tumour (Figure 3 A) along the horizontal 
line of the cursor. The highlighting in the intensity profile indicates the location of the tumour.  
 
Figure 3 shows small malignant lung nodules  distally located (A, B, C, F) and near mediastinum (B, E). PET-CT 
algorithm provides better delineation of tumour boundaries than PET region growing segmentation that suffers from 
insufficient resolution. CT-only algorithm may be negatively affected by other structures with similar attenuation, such 
as vessels, airways, lung wall, and others.  Spatially co-registered PET and CT data are assumed. 
 
 
 
 A     B 
 
  C       D 
   E         F 
 
Figure 3  From left: lung lesion in CT image (1), PET only result (2), new PET-CT algorithm result  (3), binary 
difference image defined as 3-2 (4). Top row: coronal plane, bottom: axial plane.  
 
 
 
5.  CONCLUSIONS 
 
Integration of PET and CT segmentation enables automated tumor delineation when PET-only based methods fail, such 
as in the case of tumors located in liver or proximity of structures with high normal FDG uptake. PET provides robust 
detection and a conservative tumor structure delineation, used as an initialization for CT segmentation.  CT intensity 
models learned on lesion and background then provide the basis for testing the class of each voxel, and the classification 
is probabilistically integrated with PET classification to derive the final improved result. The algorithm requires 
minimal user interaction and proves the potential of combining PET and CT information for robust and accurate tumor 
segmentation.  More sophisticated PET/CT information integration algorithms are under investigation and the outcome 
will eventually be included as a part of a segmentation toolbox within computer-aided diagnosis software developed by 
Siemens Medical Solutions.  
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